HC Wainwright Raises BNGO Price Target to $11.00

HC Wainwright & Co. has maintained a "Buy" rating for Bionano Genomics (BNGO) and raised its price target from $10 to $11, a 10% increase. Analyst Yi Chen anticipates continued growth and performance in line with the new price target. Bionano Genomics is a life sciences instrumentation company focused on genome analysis, and its Saphyr system enables researchers and clinicians to identify new diagnostics and therapeutic targets.

H.C. Wainwright & Co. has raised its price target for Bionano Genomics (BNGO) to $11 from $10, a 10% increase, while maintaining a "Buy" rating on the shares. The analyst, Yi Chen, cited sequential revenue growth in Q2 2025 as the primary reason for the upward revision [1].

Bionano Genomics, a life sciences instrumentation company, specializes in genome analysis. Its Saphyr system is designed to help researchers and clinicians identify new diagnostics and therapeutic targets. Despite a 13% decline in total revenue to $6.7 million in Q2 2025 compared to Q2 2024, the company reported a significant increase in non-GAAP gross margin to 52% from 35% a year ago, indicating improved profitability [2].

The company also experienced a 17% year-over-year increase in flow cell sales, reflecting strong demand and utilization among existing customers. Non-GAAP operating expenses were reduced by 53% year-over-year, showcasing effective cost management [2]. For the full year 2025, Bionano Genomics expects revenue to be in the range of $26 million to $30 million, with Q3 revenue guidance of $6.7 million to $7.2 million [2].

Analyst Yi Chen anticipates continued growth and performance in line with the new price target. The company's strategic focus on AI-driven software development and the successful expansion of its VIA software, widely accepted as a gold standard for CNV analysis, are key drivers for future growth [1].

References:
[1] https://www.tipranks.com/news/the-fly/bionano-genomics-price-target-raised-to-11-from-10-at-h-c-wainwright-thefly
[2] https://finance.yahoo.com/news/bionano-genomics-inc-bngo-q2-072343258.html